MaaT033 to ensure optimal intestinal microbiota to improve survival of patients receiving allo-HSCT: PHOEBUS trial

Date : December 2, 2024

[image_with_animation image_url=”13640″ animation=”Fade In” hover_animation=”none” alignment=”” border_radius=”none” box_shadow=”none” image_loading=”default” max_width=”100%” max_width_mobile=”default” img_link=”https://www.maatpharma.com/wp-content/uploads/2024/11/poster-SITC-2024-IMPRESSION.pdf”]